| 1 |
What is the primary function of AI in the medical imaging industry?
|
|
|
AI in medical imaging is primarily focused on making diagnoses more accurate, timely, and reliable, which directly translates to improved patient outcomes because better detection means earlier and more effective treatment. |
The primary function of AI in medical imaging is to help radiologists and healthcare professionals detect diseases more accurately and quickly,Assist in analyzing images (like X-rays, MRIs, CT scans) with high precision,Support better diagnosis, treatment planning, and monitoring,Ultimately, improve patient outcomes by enabling earlier and more reliable detection of medical conditions. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
Acts as a second medical opinion AI supports radiologists by offering an extra, reliable perspective on imaging results. |
A key benefit of AI in radiology highlighted in the article is that AI systems can serve as a second medical opinion by providing an additional layer of analysis to help radiologists identify abnormalities or confirm findings,Improving diagnostic confidence and reducing errors,Supporting better clinical decision-making. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
Understanding and knowledge of AI technology AI literacy means being informed about AI to use it effectively and responsibly. |
According to the article, AI literacy refers to having a basic understanding of how AI works,Being knowledgeable about AI capabilities and limitations,Knowing how to interpret AI outputs and make informed decisions,Being able to engage critically with AI tools in relevant fields like healthcare. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of the AI machines is irrelevant and not a factor influencing AI acceptance in healthcare. |
The acceptability of AI among healthcare professionals depends on factors like Trust in AI systems — confidence that AI provides accurate, reliable results,Integration with existing workflows — AI tools need to fit smoothly into daily clinical practices,System understanding — how well healthcare workers understand AI’s functions and limitations,Technology receptiveness — openness to adopting new technologies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Affects healthcare professionals’ decision to use AI. — social influence shapes acceptance and use of AI in healthcare. |
According to the article, social influence plays a key role in AI acceptability by impacting how healthcare professionals perceive AI tools,Influencing their willingness to adopt and use AI based on opinions and behaviors of colleagues, leaders, and professional networks,Shaping the overall culture around AI usage in healthcare settings |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
These concerns arise because AI challenges traditional roles, and people naturally fear change that threatens their livelihood, authority, and the quality of patient care. Addressing these fears requires transparency, training, and involving healthcare workers in AI integration. |
A common perceived threat regarding AI usage in healthcare is the fear that AI might replace human healthcare workers, especially doctors and radiologists,This can lead to job insecurity and resistance to adopting AI technologies,Concerns about losing the human touch and professional judgment in patient care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
Designing human-centred AI systems focusing on user needs and collaboration is essential for increasing AI acceptability among medical professionals. |
According to the article, increasing AI acceptability among medical professionals depends on Creating AI systems that are designed with the users’ needs, workflows, and concerns in mind,Ensuring AI supports rather than replaces healthcare workers,Focusing on usability, transparency, trust, and collaboration between humans and AI,Making AI tools easy to understand and integrate into clinical practice. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
Factors like value proposition and integration with workflows these are key components of the system usage category in AI acceptability. |
According to the article, the system usage category of AI acceptability factors includes How well the AI system fits into existing clinical workflows,The value proposition — whether the system provides clear benefits like improved efficiency or accuracy,Ease of use and compatibility with day-to-day tasks of healthcare professionals. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Affects views on AI based on compatibility with professional values ethical considerations shape healthcare professionals’ acceptance of AI. |
Ethicality impacts AI acceptability among healthcare professionals by Influencing whether AI systems align with their professional ethics and responsibilities,Affecting trust and willingness to use AI if the technology respects patient privacy, fairness, and transparency,Helping professionals feel that AI supports, rather than conflicts with, their moral duties and standards. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Considering user experience and system integration deeply a key methodological approach for future AI acceptability research. |
The article emphasizes that future studies on AI acceptability should Focus on the user experience of healthcare professionals,Examine how well AI systems integrate into existing workflows and clinical settings,Understand practical challenges and facilitators from the perspective of users,Go beyond just technical performance or economic factors to ensure successful adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
To replace lost dopamine neurons this directly targets the root cause of Parkinson’s motor symptoms. |
The primary objective of using human embryonic stem cells (hESCs) in treating Parkinson’s disease is to Replace the dopamine-producing neurons in the brain that are lost or damaged due to the disease.Restore normal dopamine levels, which are critical for controlling movement and coordination.Potentially reverse or significantly reduce motor symptoms like tremors, rigidity, and slowed movement. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Monkey chosen for their close physiological resemblance to humans in testing stem cell-based Parkinson’s disease therapies. |
In the study involving stem cell therapy for Parkinson’s disease (PD), monkeys (non-human primates) were used to test the stem cell-derived dopaminergic neuron products (often referred to as Stem-PD or similar).
Why monkeys? Their brain structure and function are more similar to humans than those of rodents.They show Parkinson-like symptoms when dopaminergic neurons are damaged. This makes them a reliable model for assessing Safety (e.g., risk of tumor formation),Efficacy e.g., improvements in motor function ,Integration of transplanted neurons into the brain. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
|
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
Phase one and 2A — the early-stage clinical trial phase for testing safety and initial efficacy of Stem-PD in Parkinson’s patients. |
The clinical trial phase mentioned for Stem-PD (stem cell-based therapy for Parkinson’s disease) is Phase 1/2a, which combines:Phase 1 – Focused on safety:Determines if the treatment is safe to use in humans,Monitors for adverse effects and appropriate dosage,Phase 2a – Begins to assess early signs of efficacy: Evaluates whether the therapy shows signs of improving symptoms,Continues monitoring safety over time. This combined approach is common in first-in-human trials for novel treatments like those involving human embryonic stem cells. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
|
|
Under GMP compliant conditions — ensuring the stem PD product is safe, consistent, and ready for clinical application. |
The Stem-PD product is manufactured under GMP-compliant (Good Manufacturing Practice) conditions, which ensures: Safety and quality control in the production of stem cell-based therapies,Strict standards for purity, consistency, and sterility,Compliance with regulatory requirements before use in clinical trials.GMP compliance is essential for any cell-based product intended for use in humans. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
There were no adverse effects or tumor formation — confirming the Stem-PD product was safe in rat models before progressing to human trials. |
According to the article, safety testing of the Stem-PD product in rats confirmed that: No tumors were formed,No adverse effects were observed after transplantation,This outcome is essential to show that the differentiated stem cells were safe for use and did not revert to an uncontrolled growth state (which can happen with pluripotent cells if not properly prepared).These findings supported moving the therapy forward into clinical trials in humans. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells increased cognitive impairments. |
|
Transplanted cells reversed motor deficits in rats — demonstrating the potential therapeutic effect of Stem-PD in Parkinson’s disease. |
The article notes that in efficacy testing of the Stem-PD product in rats:The transplanted human embryonic stem cell-derived dopamine neurons survived,They integrated into the brain,And most importantly, they helped reverse motor deficits — the key symptom in Parkinson’s disease models.This outcome provided strong preclinical evidence that the therapy could restore dopaminergic function, making it a promising candidate for human trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
GIRK2 and ALDH1A1 — specific markers used to assess the purity of the Stem-PD batch for Parkinson’s therapy. |
In the context of assessing the purity of the Stem-PD product, which is designed to replace dopaminergic neurons lost in Parkinson’s disease, researchers used specific dopaminergic neuron subtype markers, particularly:
• GIRK2 (G-protein-coupled inwardly rectifying potassium channel 2)
• ALDH1A1 (Aldehyde dehydrogenase 1 family member A1) |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
They are used in cell patterning for specific neural fates — guiding stem cells to become the type of dopamine neurons lost in Parkinson’s disease. |
In the manufacturing of the STEM-PD product, growth factors like FGF8b (Fibroblast Growth Factor 8b) and SHH (Sonic Hedgehog) are critical for:Directing the differentiation of human embryonic stem cells (hESCs),Patterning the cells toward a midbrain dopaminergic neuron fate, specifically the A9 subtype, which is lost in Parkinson’s disease.These growth factors mimic developmental signals in the embryo that guide the formation of dopaminergic neurons in the midbrain. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
Recovery of motor function — the primary measure of success for evaluating the efficacy of stem cell therapy in Parkinson’s disease animal models. |
In the pre-clinical trials for the Stem-PD product in rats, the key outcome measured for efficacy was: Recovery of motor function:This is because Parkinson’s disease primarily affects motor control due to the loss of dopamine-producing neurons in the midbrain. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|